Ross Hansen
Physician Assistant · Wakefield, NENPI 1679702815
Payments from drug & device makers
What this record shows
This record is dominated by grants: $10,000 of the $12,128 with a category attached, or 82.5%. Medtronic accounts for 82.5% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2024 at $10,366 and has fallen 96.5% since, to $363 in 2025. Among physician assistant clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 150 payments — averaging $80.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$10K
- AbbVie$451
- Amgen$296
- Novo Nordisk$296
- Astellas Pharma US Inc$187
- Lilly USA, LLC$133
- plus $764 from 23 others
What the payments were for
- Grants$10,00082%
- Food & beverage$2,12818%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 1 | $10,000 |
| AbbVie | 38 | $451 |
| Amgen | 23 | $296 |
| Novo Nordisk | 19 | $296 |
| Astellas Pharma US Inc | 11 | $187 |
| Lilly USA, LLC | 10 | $133 |
| Pfizer | 7 | $106 |
| Boehringer Ingelheim | 6 | $94 |
| Daiichi Sankyo Inc. | 4 | $54 |
| Novartis | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
| Bayer | 3 | $49 |
| AstraZeneca | 2 | $36 |
| Biohaven Pharmaceuticals, Inc. | 2 | $34 |
| Idorsia Pharmaceuticals US Inc | 2 | $30 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $28 |
| GSK | 2 | $28 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $24 |
| Chiesi USA, Inc. | 1 | $20 |
| Sanofi | 1 | $18 |
| Dexcom, Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Biogen | 1 | $17 |
| Rhythm Pharmaceuticals, Inc. | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Exact Sciences | 1 | $16 |
| Merck | 1 | $15 |
| Organogenesis Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $11 |
How this compares
$12,128 in reported general payments places this provider in the 95th percentile of 1,127 physician assistant providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 63 | $49,618 |
| EliquisApixaban | 91 | $49,123 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 27 | $19,748 |
| JanuviaSitagliptin Phosphate | 30 | $16,921 |
| OzempicSemaglutide | 13 | $11,798 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $9,080 |
| InvokanaCanagliflozin | 12 | $6,617 |
| Repatha SureclickEvolocumab | 11 | $5,699 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 12 | $5,250 |
| Atomoxetine Hcl | 13 | $2,831 |
| Atorvastatin Calcium | 230 | $1,532 |
| Gabapentin | 120 | $1,081 |
| Omeprazole | 103 | $959 |
| Tamsulosin Hcl | 93 | $909 |
| Pantoprazole Sodium | 116 | $892 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $94 | $49,61863 claims |
| PfizerEliquis | $106 | $49,12391 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $28 | $24,99839 claims |
| MerckJanuvia | $15 | $16,92130 claims |
| Novo NordiskOzempic | $296 | $11,79813 claims |
| Johnson & JohnsonInvokana | $11 | $6,61712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,127 physician assistant providers in Nebraska.
Other physician assistant in Wakefield
- Kimberly GatesOmaha$109K
- Kandice DoleshOmaha$106K
- Ronda FoleyElkhorn$64K
- Kathryn KestiOmaha$34K
- Sarah GretemanOmaha$24K
- Joel JasaGrand Island$18K
- Christopher BeasleyOmaha$15K
- Courtney MaresLincoln$13K
- Corrine GiggeeOmaha$12K
- Austin DuerksenOmaha$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.